glp-1 risks New study finds nutritional in users of drugs “Muscle health depends on sufficient protein intake and regular physical activity, especially resistance exercise. W/ GLP-1s reduced appetite can make it harder risks of using glp 1

In fact, some papers actually increase the difficulty of an exercise if participants have a decrease in pain

Retatrutide (LY3437943) is an investigational triple hormone receptor agonist that activates: GLP-1 (glucagon-like peptide-1) receptor GIP (glucose-dependent insulinotropic polypeptide) receptor Glucagon (GCG) receptor This triple G mechanism targets multiple pathways for appetite control, insulin sensitivity, glucose regulation, and energy/fat metabolismpotentially offering greater effects than dual (GLP-1/GIP) or single agonists

This number is projected to be greater than 150 million by 2050 [1]

Where CAP is frequently exacerbated by high smoking rates and exposure to air pollution, both of which aggravate respiratory problems and increase susceptibility to infections

CBS News Medical Contributor Celine Gounder is here to help us make sense of it all